Chronic Hepatitis B
Stories
-
GlaxoSmithKline posts results of Phase 3 B-Well 2 study of bepirovirsen in chronic hepatitis B
The study enrolled 857 participants and completed primary data collection on November 3, 2025. Results were first posted on ClinicalTrials.gov on November 20, 2026.